| Fund ID | 805-7140477872 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Alerce Medical Technology Partners, L.P. | Private Equity | $79.2M |
| Alerce Medical Technology Partners, L.P., Class 2023-2 | Private Equity | $37.1M |
| Alerce Medical Technology Partners, L.P., Class 2024-1 | Private Equity | $37M |
Srx Investment II, L.P. reports $6.3 million in gross assets, among the top 82% of private funds by size.
Srx Investment II, L.P. is managed by Alerce Investment Management, L.P.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.